Drug Shortage Report for GABAPENTIN

Last updated on 2017-08-10 History
Report ID 16504
Drug Identification Number 02246316
Brand name GABAPENTIN
Common or Proper name GABAPENTIN
Company Name SIVEM PHARMACEUTICALS ULC
Market Status MARKETED
Active Ingredient(s) GABAPENTIN
Strength(s) 400MG
Dosage form(s) CAPSULE
Route of administration ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2017-07-17
Estimated end date
Actual end date 2017-08-09
Shortage status Resolved
Updated date 2017-08-10
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 4705 DOBRIN STREET
SAINT-LAURENT, QUEBEC
CANADA H4R 2P7
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-07-19 English Compare
v2 2017-07-19 French Compare
v3 2017-08-10 English Compare

Showing 1 to 3 of 3